EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PhenoDEL: A Novel Screening Strategy Based on Intracellular Protein Degradation Activity

Yuichi Onda iD, Yurika Ochi iD, Toshihiro Araki, Miho Kageoka-Takahashi, Shuzo Takeda, Kazunori Yamada, Takehiko Ueda, Ken Ohno, Minoru Tanaka iD, Daiki Sakai, Miki Hasegawa iD, Yoshihito Tanaka

ACS Chemical Biology · 2026

DOI: 10.1021/acschembio.6c00234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Yuichi Onda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tanabe Pharma Corporation, Kanagawa227-0033, Japan. Hauptthemen laut MEDLINE: Proteolysis, Single-Cell Analysis, Small Molecule Libraries. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD), including proteolysis targeting chimeras (PROTACs) and molecular glue degraders (MGDs), is a promising therapeutic approach. However, systematic discovery of such small molecules remains a major challenge. Here, we present PhenoDEL, a novel phenotypic DNA-encoded library (DEL) screening platform that integrates one-bead one-compound DEL (OBOC-DEL) with the Beacon optofluidic system for single-cell analysis. By coculturing individual OBOC-DEL beads and engineered reporter cells in nanoliter-scale chambers, PhenoDEL enables time-resolved, single-cell phenotypic evaluation and direct linkage between compound identity and intracellular response. As a proof-of-concept, we demonstrate discrimination of active and inactive on-bead compounds using an FKBP12F36V-EGFP degradation reporter in PC-3 cells, followed by DNA barcode decoding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisSingle-Cell AnalysisSmall Molecule LibrariesHumansProteolysis Targeting ChimeraCell Line, TumorDNAGene LibraryGreen Fluorescent Proteins

Substanzen

Proteolysis Targeting ChimeraSmall Molecule LibrariesDNAGreen Fluorescent Proteins

Autor:innen und Institutionen

  • Tanabe Pharma Corporation, Kanagawa227-0033, Japan.
  • Nikon Corporation, Tokyo140-8601, Japan.

ORCID-Profile: Yuichi Onda, Yurika Ochi, Minoru Tanaka, Miki Hasegawa

Zitieren

APA

Onda, Y., Ochi, Y., Araki, T., Kageoka-Takahashi, M., Takeda, S., Yamada, K., Ueda, T., Ohno, K., Tanaka, M., Sakai, D., Hasegawa, M., & Tanaka, Y. (2026). PhenoDEL: A Novel Screening Strategy Based on Intracellular Protein Degradation Activity. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00234

Vancouver

Onda Y, Ochi Y, Araki T, Kageoka-Takahashi M, Takeda S, Yamada K, et al. PhenoDEL: A Novel Screening Strategy Based on Intracellular Protein Degradation Activity. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00234

BibTeX
@article{Onda2026,
  author = {Onda, Yuichi and Ochi, Yurika and Araki, Toshihiro and Kageoka-Takahashi, Miho and Takeda, Shuzo and Yamada, Kazunori and Ueda, Takehiko and Ohno, Ken and Tanaka, Minoru and Sakai, Daiki and Hasegawa, Miki and Tanaka, Yoshihito},
  title = {PhenoDEL: A Novel Screening Strategy Based on Intracellular Protein Degradation Activity},
  journal = {ACS Chemical Biology},
  year = {2026},
  doi = {10.1021/acschembio.6c00234}
}
Kostenlos starten →